Home - Products - PI3K/Akt/mTOR signaling - PI3K - BPR1J-097 hydrochloride (1327167-19-0(free base))

BPR1J-097 hydrochloride (1327167-19-0(free base))

CAS No.

BPR1J-097 hydrochloride (1327167-19-0(free base)) ( —— )

Catalog No. M17703 CAS No.

BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 94 Get Quote
10MG 154 Get Quote
50MG 473 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BPR1J-097 hydrochloride (1327167-19-0(free base))
  • Note
    Research use only, not for human use.
  • Brief Description
    BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.
  • Description
    BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    FLT3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    --
  • Formula Weight
    553.07
  • Molecular Formula
    C27H29ClN6O3S
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)C4=CC(=CC=C4)NS(=O)(=O)C5=CC=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lin WH, et al. BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML. Br J Cancer. 2012 Jan 31;106(3):475-81.
molnova catalog
related products
  • IPI-549

    IPI-549 (IPI549) is apotent, highly selective, orally active inhibitor of PI3Kγ with IC50 of 16 nM.

  • Palosuran hydrochlor...

    Palosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM.

  • Umbralisib

    Umbralisib (RP5264,TGR1202, TGR-1202) is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.